1. Home
  2. DAN vs SUPN Comparison

DAN vs SUPN Comparison

Compare DAN & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dana Incorporated

DAN

Dana Incorporated

HOLD

Current Price

$36.00

Market Cap

3.3B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.22

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAN
SUPN
Founded
1904
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.0B
IPO Year
1998
2010

Fundamental Metrics

Financial Performance
Metric
DAN
SUPN
Price
$36.00
$48.22
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$40.60
$61.60
AVG Volume (30 Days)
844.4K
443.9K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
1.34%
N/A
EPS Growth
264.10
N/A
EPS
0.64
N/A
Revenue
$7,500,000,000.00
$392,755,000.00
Revenue This Year
$1.89
$22.70
Revenue Next Year
$4.59
$19.14
P/E Ratio
$57.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.16
$29.16
52 Week High
$39.56
$59.68

Technical Indicators

Market Signals
Indicator
DAN
SUPN
Relative Strength Index (RSI) 50.41 39.88
Support Level $34.66 $47.58
Resistance Level $36.28 $52.26
Average True Range (ATR) 1.34 1.56
MACD -0.26 -0.21
Stochastic Oscillator 26.73 18.87

Price Performance

Historical Comparison
DAN
SUPN

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: